Epigenetic Epidemiology of Atherosclerosis

[1]  Reid F. Thompson,et al.  Tissue‐specific dysregulation of DNA methylation in aging , 2010, Aging cell.

[2]  J. Venter,et al.  Multiple personal genomes await , 2010, Nature.

[3]  P. Laird,et al.  DNA Methylation as a Biomarker for Cardiovascular Disease Risk , 2010, PloS one.

[4]  G. Palomaki,et al.  Association between 9p21 genomic markers and heart disease: a meta-analysis. , 2010, JAMA.

[5]  Jason H. Moore,et al.  BIOINFORMATICS REVIEW , 2005 .

[6]  C. Glass,et al.  Efficient Regulation of VEGF Expression by Promoter-Targeted Lentiviral shRNAs Based on Epigenetic Mechanism: A Novel Example of Epigenetherapy , 2009, Circulation research.

[7]  A. Gabory,et al.  Sexual dimorphism in environmental epigenetic programming , 2009, Molecular and Cellular Endocrinology.

[8]  Kohta Ikegami,et al.  Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. , 2009, The International journal of developmental biology.

[9]  Sang-Woon Choi,et al.  Too much folate: a risk factor for cancer and cardiovascular disease? , 2009, Current opinion in clinical nutrition and metabolic care.

[10]  D. Hajjar,et al.  Inflammation at the molecular interface of atherogenesis: an anthropological journey. , 2008, The American journal of pathology.

[11]  K. Morris,et al.  Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells , 2008, PLoS genetics.

[12]  L. Lanting,et al.  Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice , 2008, Circulation research.

[13]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[14]  R. Weindruch,et al.  A methyl‐deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate , 2008, The Prostate.

[15]  J. Kumar,et al.  Detection of altered global DNA methylation in coronary artery disease patients. , 2008, DNA and cell biology.

[16]  D. Corey,et al.  Antisense transcripts are targets for activating small RNAs , 2008, Nature Structural &Molecular Biology.

[17]  S. Beck,et al.  Future impact of integrated high-throughput methylome analyses on human health and disease. , 2008, Journal of genetics and genomics = Yi chuan xue bao.

[18]  L. Lanting,et al.  Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes , 2008, Proceedings of the National Academy of Sciences.

[19]  A. Feinberg,et al.  Intra-individual change over time in DNA methylation with familial clustering. , 2008, JAMA.

[20]  Yang Shi,et al.  Mechanisms involved in the regulation of histone lysine demethylases. , 2008, Current opinion in cell biology.

[21]  Sang-Woon Choi,et al.  Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. , 2008, The Journal of nutritional biochemistry.

[22]  C. Matouk,et al.  Epigenetic Regulation of Vascular Endothelial Gene Expression , 2008, Circulation research.

[23]  W. Liao,et al.  Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation , 2008, Circulation research.

[24]  S. Mandal,et al.  Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. , 2008, Biochimica et biophysica acta.

[25]  R. Wade,et al.  Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia* , 2007, Journal of Biological Chemistry.

[26]  M. Shimabukuro,et al.  Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. , 2007, Journal of psychiatric research.

[27]  O. McDonald,et al.  Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. , 2007, American journal of physiology. Cell physiology.

[28]  P. Szabó,et al.  CTCF Is the Master Organizer of Domain-Wide Allele-Specific Chromatin at the H19/Igf2 Imprinted Region , 2007, Molecular and Cellular Biology.

[29]  Peter A. Jones,et al.  DNA methylation: The nuts and bolts of repression , 2007, Journal of cellular physiology.

[30]  M. DeRuiter,et al.  Intrauterine Exposure to Maternal Atherosclerotic Risk Factors Increases the Susceptibility to Atherosclerosis in Adult Life , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  E. Kampman,et al.  High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells , 2007, British Journal of Nutrition.

[32]  K. Morris,et al.  Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells , 2007, Proceedings of the National Academy of Sciences.

[33]  P. Collas,et al.  Programming the genome in embryonic and somatic stem cells , 2007, Journal of cellular and molecular medicine.

[34]  T. Ekström,et al.  Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? , 2007, Journal of internal medicine.

[35]  Jiantuan Xiong,et al.  Ligands of peroxisome proliferator-activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene. , 2007, Acta biochimica et biophysica Sinica.

[36]  C. Allis,et al.  Epigenetics: A Landscape Takes Shape , 2007, Cell.

[37]  D. Corey,et al.  Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. , 2007, Nature chemical biology.

[38]  W. Herrmann,et al.  Decreased p66Shc promoter methylation in patients with end-stage renal disease , 2007, Clinical chemistry and laboratory medicine.

[39]  J. Issa,et al.  Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. , 2007, Biochimica et biophysica acta.

[40]  R. Place,et al.  Small dsRNAs induce transcriptional activation in human cells , 2006, Proceedings of the National Academy of Sciences.

[41]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[42]  Philip Smith,et al.  Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65* , 2006, Journal of Biological Chemistry.

[43]  Marta Boeke,et al.  Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription. , 2006, Biochimica et biophysica acta.

[44]  D. Corey,et al.  Involvement of AGO1 and AGO2 in mammalian transcriptional silencing , 2006, Nature Structural &Molecular Biology.

[45]  O. McDonald,et al.  PRISM/PRDM6, a Transcriptional Repressor That Promotes the Proliferative Gene Program in Smooth Muscle Cells , 2006, Molecular and Cellular Biology.

[46]  I. Weaver,et al.  Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Castro,et al.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview , 2006, Journal of Inherited Metabolic Disease.

[48]  A. Riggs,et al.  The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. , 2005, RNA.

[49]  O. McDonald,et al.  Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. , 2005, The Journal of clinical investigation.

[50]  Amitabh Sharma,et al.  Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies , 2006, Lipids in Health and Disease.

[51]  Guillaume J. Filion,et al.  The Human Enhancer Blocker CTC-binding Factor Interacts with the Transcription Factor Kaiso* , 2005, Journal of Biological Chemistry.

[52]  I. Weaver,et al.  Reversal of Maternal Programming of Stress Responses in Adult Offspring through Methyl Supplementation: Altering Epigenetic Marking Later in Life , 2005, The Journal of Neuroscience.

[53]  F. Prósper,et al.  Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia , 2005, Oncogene.

[54]  H. Kwon,et al.  Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[55]  J. Fish,et al.  Epigenetic Basis for the Transcriptional Hyporesponsiveness of the Human Inducible Nitric Oxide Synthase Gene in Vascular Endothelial Cells1 , 2005, The Journal of Immunology.

[56]  S. Kono,et al.  Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma , 2005, Cancer science.

[57]  Tony Kouzarides,et al.  Reversing histone methylation , 2005, Nature.

[58]  Antonio Porro,et al.  In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  A. Devlin,et al.  Tissue-specific Changes in H19 Methylation and Expression in Mice with Hyperhomocysteinemia* , 2005, Journal of Biological Chemistry.

[60]  J. Fish,et al.  The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code* , 2005, Journal of Biological Chemistry.

[61]  G. Hannon,et al.  RNA-interference-directed chromatin modification coupled to RNA polymerase II transcription , 2005, Nature.

[62]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[63]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[64]  Da-Zhi Wang,et al.  Modulation of Smooth Muscle Gene Expression by Association of Histone Acetyltransferases and Deacetylases with Myocardin , 2005, Molecular and Cellular Biology.

[65]  K. Morris,et al.  Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells , 2004, Science.

[66]  J. Fish,et al.  The Cell-specific Expression of Endothelial Nitric-oxide Synthase , 2004, Journal of Biological Chemistry.

[67]  T. Bottiglieri,et al.  Cerebral Vascular Dysfunction Mediated by Superoxide in Hyperhomocysteinemic Mice , 2004, Stroke.

[68]  Esteban Ballestar,et al.  DNA Methylation Polymorphisms Precede Any Histological Sign of Atherosclerosis in Mice Lacking Apolipoprotein E* , 2004, Journal of Biological Chemistry.

[69]  C. Liu,et al.  Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. , 2004, Experimental cell research.

[70]  Rama Natarajan,et al.  In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions* , 2004, Journal of Biological Chemistry.

[71]  S. Ylä-Herttuala,et al.  DNA methylation, smooth muscle cells, and atherogenesis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[72]  W. Greene,et al.  Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation , 2003, Journal of Molecular Medicine.

[73]  R. Castro,et al.  Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. , 2003, Clinical chemistry.

[74]  T. Motoyama,et al.  Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples , 2003, Oncogene.

[75]  E. Falk,et al.  Hypercholesterolemia in pregnant mice does not affect atherosclerosis in adult offspring. , 2003, Atherosclerosis.

[76]  T. Kouzarides,et al.  The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. , 2003, Nucleic acids research.

[77]  B. Simon,et al.  Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. , 2003, The Journal of clinical endocrinology and metabolism.

[78]  M. Goggins,et al.  Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. , 2003, Journal of the National Cancer Institute.

[79]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[80]  B. Richardson,et al.  Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. , 2002, The Journal of nutrition.

[81]  I. Pogribny,et al.  Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. , 2002, The Journal of nutrition.

[82]  P. Qiu,et al.  Histone Acetylation and Recruitment of Serum Responsive Factor and CREB-Binding Protein Onto SM22 Promoter During SM22 Gene Expression , 2002, Circulation research.

[83]  C. Glass,et al.  Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray , 2002, Circulation.

[84]  P. Holt,et al.  Differential Patterns of Methylation of the IFN-γ Promoter at CpG and Non-CpG Sites Underlie Differences in IFN-γ Gene Expression Between Human Neonatal and Adult CD45RO− T Cells1 , 2002, The Journal of Immunology.

[85]  M. Turunen,et al.  DNA hypomethylation and methyltransferase expression in atherosclerotic lesions , 2002, Vascular medicine.

[86]  Sandy D. Westerheide,et al.  The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.

[87]  C. Napoli,et al.  Maternal Hypercholesterolemia Enhances Atherogenesis in Normocholesterolemic Rabbits, Which Is Inhibited by Antioxidant or Lipid-Lowering Intervention During Pregnancy: An Experimental Model of Atherogenic Mechanisms in Human Fetuses , 2000, Circulation research.

[88]  M. Matzke,et al.  Transcriptional silencing and promoter methylation triggered by double‐stranded RNA , 2000, The EMBO journal.

[89]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[90]  C. Plass,et al.  Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. , 2000, Cardiovascular research.

[91]  B. Jacobsen,et al.  Cloning of a Mammalian Transcriptional Activator That Binds Unmethylated CpG Motifs and Shares a CXXC Domain with DNA Methyltransferase, Human Trithorax, and Methyl-CpG Binding Domain Protein 1 , 2000, Molecular and Cellular Biology.

[92]  Y. T. Lee,et al.  Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. , 2000, Circulation.

[93]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[94]  C. Glass,et al.  Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study , 1999, The Lancet.

[95]  J. Issa,et al.  Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. , 1999, Cardiovascular research.

[96]  K. Airenne,et al.  Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[97]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[98]  Hong Wang,et al.  Homocysteine and hypomethylation. A novel link to vascular disease. , 1999, Trends in cardiovascular medicine.

[99]  F. Veith,et al.  Diagnosis and treatment of chronic lower extremity ischemia , 1998, Vascular medicine.

[100]  M. Gassmann,et al.  Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. , 1998, European journal of biochemistry.

[101]  S. Marklund,et al.  Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[102]  D. Harrison,et al.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[103]  M. Tatsuta,et al.  Structure and expression of the human SM22alpha gene, assignment of the gene to chromosome 11, and repression of the promoter activity by cytosine DNA methylation. , 1997, Journal of biochemistry.

[104]  M. Mass,et al.  CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. , 1997, Biochemical and biophysical research communications.

[105]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[106]  Masahito Hayashi,et al.  Induction of ICAM‐1 and LFA‐3 by Tax1 of human T‐cell leukemia virus type 1 and mechanism of down‐regulation of ICAM‐1 or LFA‐1 in adult‐T‐cell‐leukemia cell lines , 1995, International journal of cancer.

[107]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[108]  T. Deuel,et al.  Site-specific methylation inhibits transcriptional activity of platelet-derived growth factor A-chain promoter. , 1993, The Journal of biological chemistry.

[109]  R. Wissler.  Update on the pathogenesis of atherosclerosis. , 1991, The American journal of medicine.

[110]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[111]  P. Winocour,et al.  Effect of the amount and type of dietary fat on platelet function, platelet survival and response to continuous aortic injury in rats. , 1987, Atherosclerosis.

[112]  V. L. Wilson,et al.  DNA methylation decreases in aging but not in immortal cells. , 1983, Science.

[113]  M. Ehrlich,et al.  Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.

[114]  T. Steinbach,et al.  Alteration of chromatin in early experimental arteriosclerosis. , 1980, Artery.

[115]  E. Benditt,et al.  Evidence for a monoclonal origin of human atherosclerotic plaques. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[116]  G. Rose.  Familial Patterns in Ischaemic Heart Disease , 1964, British journal of preventive & social medicine.

[117]  S. Limbosch-Rolin.  Les effets du β-mercaptoethanol et du dithiodiglycol sur la croissance de Escherichia coli et de Saccharomyces cerevisiae , 1963 .